Detailed profile of Crocus sativus

International Journal of Pharma and Bio Sciences

Volumn 2, Issue 1, 2011, Pages 530-540

  Champalal, Katariya Dhirajkumar ^a   Nilakshi, Nerkar ^a   Vijay, Gadiya Raj ^b   Abhyankar, M M ^a  

^a PDEA's Seth Govind Raghunath Sable College of Pharmacy   (India)

^b Research Associate Centaur Pharmaceuticals   (India)

Author keywords

Affron; Crocetin; Crocus sativus; Safranal

Indexed keywords

ALKALOID; ANTHOCYANIN; BETA CAROTENE; CATALASE; CROCETIN; CROCIN; CROCUS SATIVUS EXTRACT; DIMETHYLCROCETIN; FLAVONOID; GLUTATHIONE TRANSFERASE; HERBACEOUS AGENT; KAEMPFEROL; PICROCROCIN; PLANT MEDICINAL PRODUCT; SAFRANAL; SAPONIN; TANNIN DERIVATIVE; TRANS CROCIN 4; UNCLASSIFIED DRUG;

ANTICONVULSANT ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTINOCICEPTION; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTHRITIS; ARTICLE; ASCITES TUMOR; ASTHMA; CANCER INHIBITION; CHRONIC INFLAMMATION; COUGHING; CROCUS SATIVUS; DIGESTIVE SYSTEM FUNCTION DISORDER; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG EFFICACY; DRUG SAFETY; ENZYME ACTIVITY; ENZYME INHIBITION; ESTRUS CYCLE; EYE BLOOD FLOW; FATALITY; HEPATOMEGALY; HUMAN; HYPERTENSION; IMMUNOMODULATION; INFLAMMATION; KIDNEY DISEASE; LD 50; MENSTRUATION DISORDER; NONHUMAN; PAIN; PHYTOCHEMISTRY; RETINA; SEIZURE; SKIN DISEASE; SMOOTH MUSCLE RELAXATION; SPLENOMEGALY; THROMBOCYTE AGGREGATION INHIBITION; UTERUS;

CROCUS SATIVUS;

EID: 84855332287     PISSN: None     EISSN: 09756299     Source Type: Journal    
DOI: None     Document Type: Article

References (83)

1. Hedrick. U. P. Sturtevant's Edible Plants of the World. Dover Publications, ISBN 0-486-20459-6, (1972).
2. Grieve. A, Modern Herbal. Penguin, ISBN 0-14-046-440-9, (1984).
3. Chiej. R. Encyclopaedia of Medicinal Plants. MacDonald, ISBN 0-356-10541-5, (1984).
4. Holtom. J. and Hylton. W. Complete Guide to Herbs. Rodale Press, ISBN 0-87857-262-7, (1979).
5. Lust. J. The Herb Book. Bantam books, ISBN 0-553-23827-2, (1983).
6. Harrison. S. Wallis. M. Masefield. G. The Oxford Book of Food Plants. Oxford University Press, (1975).
7. Facciola. S. Cornucopia - A Source Book of Edible Plants. Kampong Publications, ISBN 0-9628087-0-9, (1990).
8. Phillips. R. & Foy. N. Herbs Pan Books Ltd. London, ISBN 0-330-30725-8, (1990).
9. The Plantsman, Royal Horticultural Society, Vol. 9. (1986 - 1987).
10. Hill. A. F. Economic Botany. The Maple Press, (1952).
11. Polunin. O. and Huxley. A. Flowers of the Mediterranean. Hogarth Press, ISBN 0-7012-0784-1, (1987).
12. Bown. D. Encyclopaedia of Herbs and their Uses. Dorling Kindersley, London, ISBN 0-7513-020-31, (1995).
13. Nandan Kumar Jha, Pytopharm, Crocus sativus Feature, Article: 3-12, (2005)
14. Duke. J. A. and Ayensu. E. S. Medicinal Plants of China Reference Publications, Inc. 1985 ISBN 0-917256-20-4.
15. Ben Frik, Wyk Michael wink, Medicinal plants of the world, 3rd edition: 116, (2003)
16. Kirtikar and Basu, Indian medical plants, 2 nd edition, Vol 4th: 2463, (1993)
17. Arya Vaidya, Indian medical plants, a compendium of 500 species, Volume 2: 212
18. Akhondzadeh S, Tahmacebin Pour N, Noorbala A A, et al. Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebocontrolled trial, Phytother Res. Volume: 19:148-51, (2005).
19. Noorbala A A, Akhondzadeh S, Tahmacebi-Pour N, et al. Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. J Ethnopharmacol, Vol: 97:281-4, (2005).
20. Akhondzadeh S, Fallah-Pour H, Afkham K, et al. Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial, BMCComplement Altern Med. Vol 4:12, (2004).
21. Moshiri E, Basti AA, Noorbala AA et al. Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: A doubleblind, randomized and placebo-controlled trial. Phytomedicine, Vol Sept, (2006)
22. Akhondzadeh Basti A, Moshiri E, Noorbala AA, et al. Comparison of petal of Crocus sativus L and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trial. Prog Neuropsychopharmacol Biol Psychiatry. Vol Dec, (2006).
23. Peter Goldblatt, Ph.D - Phylogeny and classification of Iridaceae. Ann. Missouri Bot. Gard. Vol 77: 607-627, (1990).
24. McGee H, On Food and Cooking: The Science and Lore of the Kitchen, Scribner, ISBN 0-684-80001-2, (2004)
25. Katzer, G, Saffron Crocus sativus L.", Gernot Katzer's Spice Pages, Vol: Jan, (2001).
26. Deo, B, "Growing Saffron - The World's Most Expensive Spice", Crop & Food Research (New Zealand Institute for Crop & Food Research) (Vol 20) (2003)
27. Dharmananda, S, "Saffron: An Anti-Depressant Herb", Institute for Traditional Medicine, (2005)
28. Goyns, MH, Saffron, Taylor & Francis, ISBN 90-5702-394-6, (1999)
29. Indian medical plants, a companium of 500 species, Volume 2, Arya Vaidya Sala: 212
30. Abe K, Saito H. Effects of saffron extract and its constituent crocin on learning behavior and long-term potentiation. Phytother Res. Vol 14:149-52. (2000).
31. Vida JA, Foye WO, Lemke TL, Williams DA, eds. Principles of Medicinal Chemistry. London: Williams and Wilkins; 1995.
32. Cancer Lett. Feb 27, Vol:100: 23-30, (1996).
33. Garcia-Olmo DC, Riese HH, Escribano J, Ontañon J, Fernandez JA, Atienzar M, Garcia-Olmo D. Effects of long-term treatment of colon adenocarcinoma with crocin, a carotenoid from saffron (Crocus sativus L.): an experimental study in the rats. Nutr. Cancer Vol: 35(2): 120-126, (1999).
34. Abdullaev FI, Gonzalez de Mejia E. Inhibition of colony formation of Hela cells by naturally occurring and synthetic agents, BioFactors, Vol: 5(3):133-138, (1995-96).
35. Morjani H, Tarantilis P, Polissiou M, Manfait M. Growth inhibition and induction of crythroid differentiation activity by crocin, dimethylcrocetine and ß-carotene on K562 tumor cells, Anticancer Res, Vol 10: 1398- 1406, (1990).
36. Tarantilis PA, Morjani H, Polissiou M, Manfait M. Inhibition of growth and induction of differentiation promyelocytic leukemia (HL-60) by carotenoids from Crocus sativus L, Anticancer Res, Vol: 14(5A):1913-1918, (1994)
37. Nair S.C, Kurumboor S.K, Hasegawa J.H, Saffron chemoprevention in biology and medicine: a review, Cancer Biother, Vol 10(4):257-264, (1995).
38. Nair S C, Pannikar B, Pannikar K R, Antitumour activity of saffron (Crocus sativus), Cancer Lett, Vol 57(2):109-114, (1991)
39. Abdullaev F I, Frenkel G D. Effect of saffronon cell colony formation and cellular nucleic acid and protein synthesis, Bio Factors, Vol: 3(3): 43-45, 201-204, (1992).
40. Escribano J, Rios J, Fernandez JA. Isolation and cytotoxic properties of novel glycoconjugate from corms of saffron plant (Crocus sativus L.), Biochim Biophys Acta, Vol: 1426 (1): 217-222, (1999).
41. Escribano J, Diaz-Guerra MJ, Riese H H, Ontanon J, Garcia-Olmo D, Garcia-Olmo DC, Rubio A, Fernandez JA, In vitro activation of macrophages from corms of Crocus sativus L, Cancer Lett, vol 144(1):107-114, (1999)
42. Escribano J, Piqueras A, Medina J, Rubio A, Alvarez-Orti M, Fernandez JA, Production of a cytotoxic proteoglycan using callus culture of saffron corms (Crocus sativus L.), J Biotechnol, Vol 73(1):53-59, (1999).
43. Escribano J, Diaz-Guerra M J, Riese H H, Alvarez A, Proenza R, Fernandez J A, The cytotoxic effect of glucoconjugate extracted from corms of saffron plant (Crocus sativus) on human cell lines in culture, Planta Med 66(2):157-162, (2000)
44. Fernandez J A, Escribano J, Piqueras A, Medina J. A glycoconjugate from corms of saffron plant (Crocus sativus L.) inhibits root growth and affects in vitro cell viability, J Exp Bot, Vol 51:731-737, (2000).
45. Fernandez J A, Escribano J, Piqueras A, Medina J. A glycoconjugate from corms of saffron plant (Crocus sativus L.) inhibits root growth and affects in vitro cell, Sci Congr, Vol 3:125-126, (1990).
46. Nair S C, Salomi M J, Panikkar B, Pannikkar K R, Modulatory effects of Crocus-sativus and Nigella-sativa extracts on cisplatin-induced toxicity in mice, J Ethnopharmacol, Vol 5: 67-84, (1991)
47. Phytochemical methods, A guide to modern techniques of plant analysis, J. B. Harborne, Third edition: 139, (1998)
48. Abdullaev Jafarova F, Caballero-Ortega H, Riveron-Negrete L, et al. In vitro evaluation of the chemopreventive potential of saffron, Rev Invest Clin, Vol 54: 430-6, (2003).
49. Escribano J, Alonso G L, Coca-Prados M, et al. Crocin, safranal and picrocrocin from saffron (Crocus sativus L.) inhibit the growth of human cancer cells in vitro, Cancer Lett; Vol 100:23-30, (1996)
50. Abdullaev F I, Espinosa-Aguirre J J, Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials, Cancer Detect Prev, Vol 28: 426-32, (2004)
51. Molnar J, Szabo D, Pusztai R, et al. Membrane associated antitumor effects of crocine-, ginsenoside- and cannabinoid derivates. Anticancer Res, Vol: 20: 861-7, (2000).
52. Abdullaev F I, Riveron-Negrete L, Caballero-Ortega H, et al. Use of in vitro assays to assess the potential antigenotoxic and cytotoxic effects of saffron (Crocus sativus L.), Toxicol In Vitro, Vol 17:731-6, (2003).
53. Garcia-Olmo D C, Riese H H, Escribano J, et al. Effects of long-term treatment of colon adenocarcinoma with crocin, a carotenoid from saffron (Crocus sativus L.): an experimental study in the rat, Nutr Cancer, Vol: 35:120-6, (2000).
54. Hosseinzadeh H, Ramezani M, Salmani G A. Antinociceptive, anti-inflammatory, J Ethnopharmacol, Vol 73:379-385, (2000).
55. Saxena R S, Gupta B, Saxena K K, Singh R C, Prasad D N, Study of antiinflammatory activity, Indian medicinal plant. J Ethnopharmacol, Vol 11:319-330, (1984).
56. Ma S, Zhou S, Shu B, Zhou J. Pharmacological studies on Crocus glycosides I. Effects on antiinflammatory and immune function. Zhongcaoyao, Vol 29: 536-539, (1998).
57. Akhondzadeh S, et al., Crocus sativus in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial, Phytotherapy Research, Vol 19(2):148-151, (2005).
58. Medical natural products, A biosynthetic approach, Second edition, Paul M. Dewick:231.
59. Prog Neuropsychopharmacol Biol Psychiatry, (2006)
60. J Pharma Pharmacol, Vol 58(10):1385-90, (2006)
61. J. Ethnopharmacol. Vol 84(2-3): 199-203, (2003).
62. J Agric Food Chem, Vol54(23): 8762, (2006)
63. Fitoterapia. Epub, Vol 77(6): 446-8, (2006)
64. Xu GL, Yu SQ, Gong ZN, et al. Study of the effect of crocin on rat experimental hyperlipemia and the underlying mechanisms, Zhongguo Zhong Yao Za Zhi, Vol 30:369-72, (2005).
65. Eur J Pharmacol, Vol 543(1-3): 116-22, (2006)
66. Prikl Biokhim Mikrobiol, Vol 42(1): 111-6, (2006)
67. J Ocul Pharmacol Ther, Vol: 15(2):143-52, (1999)
68. Mol Cell Biochem, Vol 278(1-2): 59-63, (2005)
69. Phytother Res, Vol 19(11): 997-1000, (2005)
70. J Nat Prod, Vol 67(3): 437-40, (2004)
71. J Argic Food Chem, Vol 47(10): 4121-5, (1999)
72. J Nat Prod, Vol 65(10): 1452-6, (2002)
73. Chem. Pharm Bull (Tokyo), Vol 50(10):1305-9, (2002).
74. Life Science, Vol 69(24): 2887-98, (2001)
75. Mol Biol Rep, Vol 29(1-2):125-8, 163-6, (2002)
76. Yao Xue Xue Bao, Vol 11: 94-100, (1964)
77. Daly E S. Protective effect of cysteine and vitamin E, Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in rats, J Pharm Belg, Vol 53: 87-93, (1998).
78. Drug Chem Toxicol, Vol 24(4): 421-8, (2001)
79. Cancer Lett, Vol 144(1): 107-14, (1999)
80. J Ethnopharmacol, Vol 31(1):75-83, (1991)
81. Hossein Hosseinzadeh and Hani M Younesi, Antinociceptive and antiinflammatory effects of Crocus sativus L. stigma and petal extracts in mice. BMC Pharmacol, Vol 2: 7, (2002).
82. Loomis, T A, Essential of Toxicology. Philladelphia, Lea and Febiger.:67-78, (1968).
83. Hosseinzadeh, H.; Khosravan V, Anticonvulsant effect of Crocus sativus L. stigmas aqueous and ethanolic extracts in mice, Arch Irn Med, (2001).